ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402

BACKGROUND: Adding intensive-procarbazine, lomustine, and vincristine (iPCV) to radiotherapy (RT) prolonged progression-free (PFS) and overall survival (OS) for patients with 1p19q codeleted anaplastic oligodendroglial tumors (AOTs); some benefit was also observed for IDH-mutant non-codeleted cases...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Lassman, Andrew, Won, Minhee, Gregory Cairncross, J, Shaw, Edward, Ashby, Lynn, Souhami, Luis, Laack, Nadia, Fink, Karen, Macdonald, David, Bahary, Jean-Paul, Hartford, Alan, Whitton, Anthony, Werner-Wasik, Maria, Laperriere, Normand, Suh, John, Robinson, Clifford, Mehta, Minesh
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Adult Clinical Trials - Non-Immunologic
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados